» Articles » PMID: 16754512

Comparison of Fetal and Adult Marrow Stromal Cells in Osteogenesis with and Without Glucocorticoids

Overview
Publisher Informa Healthcare
Date 2006 Jun 7
PMID 16754512
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

To better understand the potential use of fetal marrow stromal cells (MSCs) in bone tissue engineering, we compared the ability of these cells with those of adult MSCs with respect to osteoblasts differentiation in the presence or absence of glucocorticoids. Cells were grown for 3-4 weeks in basal medium or supplemented with 100 nM dexamethasone (DEX, a synthetic glucocorticoid analog) or with 50 microM L-ascorbate and 10 mM glycerol-2-phosphate (AS+GP) or with AS+GP+DEX. At various time points in culture, the following parameters were compared between fetal and adult MSCs: cell morphology, cell proliferation, alkaline phosphatase activity, calcium (45Ca) uptake, von Kossa staining, and glucocorticoids receptor expression were analyzed. Compared with adult MSCs, fetal cells showed a less dramatic change to cuboidal morphology in DEX-containing media. Fetal MSCs in all media conditions showed higher proliferation rates and lower alkaline phosphatase activities (p < 0.001) than adult cells. Both fetal and adult MSCs responded similarly in DEX-containing media with respect to suppressing cell proliferation, stimulating alkaline phosphatase activity, and consistently accumulating calcium (usually higher in fetal cells) with subsequent formation of mineralized matrix when compared with cells cultured in AS+GP. Our findings further implicate the requirement of glucocorticoids in osteogenesis. In conclusion, compared with adult MSCs, fetal cells showed greater ability in sustaining cell proliferation and calcium uptake suggesting that they may be useful for bone tissue repair.

Citing Articles

Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes?.

Malandraki-Miller S, Lopez C, Al-Siddiqi H, Carr C Front Cardiovasc Med. 2018; 5:119.

PMID: 30283788 PMC: 6157401. DOI: 10.3389/fcvm.2018.00119.


Effects of silica-gentamicin nanohybrids on osteogenic differentiation of human osteoblast-like SaOS-2 cells.

He W, Mosselhy D, Zheng Y, Feng Q, Li X, Yang X Int J Nanomedicine. 2018; 13:877-893.

PMID: 29445277 PMC: 5810519. DOI: 10.2147/IJN.S147849.


Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes.

Tourkova I, Liu L, Sutjarit N, Larrouture Q, Luo J, Robinson L Lab Invest. 2017; 97(9):1072-1083.

PMID: 28737765 PMC: 5844701. DOI: 10.1038/labinvest.2017.62.


Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Blair H, Larrouture Q, Li Y, Lin H, Beer-Stoltz D, Liu L Tissue Eng Part B Rev. 2016; 23(3):268-280.

PMID: 27846781 PMC: 5467150. DOI: 10.1089/ten.TEB.2016.0454.


Are We Economically Efficient Enough to Increase the Potential of Proliferation of Osteoblasts by Means of Pharmacochemical Agents?.

Isyar M, Gumustas S, Yilmaz I, Sirin D, Tosun H, Mahirogullari M Open Orthop J. 2016; 10:420-430.

PMID: 27708738 PMC: 5034028. DOI: 10.2174/1874325001610010420.